目的分析氨氯地平阿托伐他汀钙片应用于治疗高血压合并冠心病患者的可行性。方法选择2016年4月~2017年1月我院接收并治疗的76例高血压合并冠心病患者,并分为两组,予以对照组患者硝苯地平片治疗,予以研究组氨氯地平阿托伐他汀钙片治疗,对比两组治疗的疗效。结果研究组治疗以后的血压、血脂水平及总有效率均优于对照组,差异有统计学意义(P<0.05)。结论氨氯地平阿托伐他汀钙片用于治疗高血压合并冠心病的可行性较高,值得推广。 Objective To analyze the feasibility of using amlodipine atorvastatin calcium tablets in the treatment of patients with hypertension and coronary heart disease. Methods From April 2016 to January 2017, 76 patients with hypertension and coronary heart disease received and treated in our hospital were divided into two groups. Patients in the control group were treated with nifedipine. Patients in the study group were treated with amlodipine Calcvastatin treatment, compared the efficacy of treatment of two groups. Results The blood pressure, blood lipid level and total effective rate of the study group were better than those of the control group after treatment, the difference was statistically significant (P <0.05). Conclusion Amlodipine atorvastatin calcium tablets for the treatment of hypertension complicated by coronary heart disease is highly feasible and worth promoting.